Ana‐Eugenia Rodríguez‐Vicente

A high proportion of cells carrying trisomy 12 is associated with a worse outcome in patients with chronic lymphocytic leukemia

Isabel González-Gascón-y-Marín, María Hernández‐Sánchez, Ana‐Eugenia Rodríguez‐Vicente et al. · Hematological Oncology · 2015 · 30 citations

The International Prognostic Index for Patients with Chronic Lymphocytic Leukemia Has the Higher Value in Predicting Overall Outcome Compared with the Barcelona-Brno Biomarkers Only Prognostic Model and the MD Anderson Cancer Center Prognostic Index

Carolina Muñoz‐Novas, María Poza-Santaella, Isabel González-Gascón-y-Marín et al. · BioMed Research International · 2018 · 23 citations · Full text

Biological significance of monoallelic and biallelic BIRC3 loss in del(11q) chronic lymphocytic leukemia progression

Miguel Quijada‐Álamo, María Hernández‐Sánchez, Ana‐Eugenia Rodríguez‐Vicente et al. · Blood Cancer Journal · 2021 · 19 citations · Full text

Dissecting the role of <i>TP53</i> alterations in del(11q) chronic lymphocytic leukemia

Miguel Quijada‐Álamo, Claudia Pérez‐Carretero, María Hernández‐Sánchez et al. · Clinical and Translational Medicine · 2021 · 13 citations · Full text

Prognosis Assessment of Early-Stage Chronic Lymphocytic Leukemia: Are We Ready to Predict Clinical Evolution Without a Crystal Ball?

Isabel González-Gascón-y-Marín, Carolina Muñoz‐Novas, Íñigo Rúa‐Figueroa et al. · Clinical Lymphoma Myeloma & Leukemia · 2020 · 11 citations

Hematological Malignancy, Lymphoid Neoplasia, Predict Clinical Evolution +12